{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T03:41:39Z","timestamp":1792899699921,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,12,14]],"date-time":"2016-12-14T00:00:00Z","timestamp":1481673600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s00404-016-4258-8","type":"journal-article","created":{"date-parts":[[2016,12,14]],"date-time":"2016-12-14T02:21:21Z","timestamp":1481682081000},"page":"459-465","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Elevated serum interleukin-37 level is a predictive biomarker of poor prognosis in epithelial ovarian cancer patients"],"prefix":"10.1007","volume":"295","author":[{"given":"Junwei","family":"Huo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaowei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajie","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,14]]},"reference":[{"issue":"1","key":"4258_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3322\/caac.21254","volume":"65","author":"RL Siegel","year":"2015","unstructured":"Siegel RL, Miller KD, Jemal A (2015) Cancer statistics, 2015. CA Cancer J Clin 65(1):5\u201329. doi: 10.3322\/caac.21254","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4258_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/GRF.0b013e31824b4611","volume":"55","author":"J Hunn","year":"2012","unstructured":"Hunn J, Rodriguez GC (2012) Ovarian cancer: etiology, risk factors, and epidemiology. Clin Obstet Gynecol 55(1):3\u201323. doi: 10.1097\/GRF.0b013e31824b4611","journal-title":"Clin Obstet Gynecol"},{"issue":"3","key":"4258_CR3","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s00404-015-3864-1","volume":"293","author":"J Paek","year":"2016","unstructured":"Paek J, Lee M, Nam EJ, Kim SW, Kim YT (2016) Clinical impact of high mobility group box 1 protein in epithelial ovarian cancer. Arch Gynecol Obstet 293(3):645\u2013650. doi: 10.1007\/s00404-015-3864-1","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"4258_CR4","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1074\/jbc.275.2.1169","volume":"275","author":"DE Smith","year":"2000","unstructured":"Smith DE, Renshaw BR, Ketchem RR, Kubin M, Garka KE, Sims JE (2000) Four new members expand the interleukin-1 superfamily. J Biol Chem 275(2):1169\u20131175","journal-title":"J Biol Chem"},{"issue":"14","key":"4258_CR5","doi-asserted-by":"crossref","first-page":"10308","DOI":"10.1074\/jbc.275.14.10308","volume":"275","author":"S Kumar","year":"2000","unstructured":"Kumar S, McDonnell PC, Lehr R, Tierney L, Tzimas MN, Griswold DE, Capper EA, Tal-Singer R, Wells GI, Doyle ML, Young PR (2000) Identification and initial characterization of four novel members of the interleukin-1 family. J Biol Chem 275(14):10308\u201310314","journal-title":"J Biol Chem"},{"issue":"11","key":"4258_CR6","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/ni.1944","volume":"11","author":"MF Nold","year":"2010","unstructured":"Nold MF, Nold-Petry CA, Zepp JA, Palmer BE, Bufler P, Dinarello CA (2010) IL-37 is a fundamental inhibitor of innate immunity. Nat Immunol 11(11):1014\u20131022. doi: 10.1038\/ni.1944","journal-title":"Nat Immunol"},{"issue":"1","key":"4258_CR7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/039463201202500105","volume":"25","author":"S Tete","year":"2012","unstructured":"Tete S, Tripodi D, Rosati M, Conti F, Maccauro G, Saggini A, Cianchetti E, Caraffa A, Antinolfi P, Toniato E, Castellani ML, Conti P, Theoharides TC (2012) IL-37 (IL-1F7) the newest anti-inflammatory cytokine which suppresses immune responses and inflammation. Int J Immunopathol Pharmacol 25(1):31\u201338","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"40","key":"4258_CR8","doi-asserted-by":"publisher","first-page":"16711","DOI":"10.1073\/pnas.1111982108","volume":"108","author":"EN McNamee","year":"2011","unstructured":"McNamee EN, Masterson JC, Jedlicka P, McManus M, Grenz A, Collins CB, Nold MF, Nold-Petry C, Bufler P, Dinarello CA, Rivera-Nieves J (2011) Interleukin 37 expression protects mice from colitis. Proc Natl Acad Sci USA 108(40):16711\u201316716. doi: 10.1073\/pnas.1111982108","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"4258_CR9","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1111\/j.1440-1746.2012.07187.x","volume":"27","author":"N Sakai","year":"2012","unstructured":"Sakai N, Van Sweringen HL, Belizaire RM, Quillin RC, Schuster R, Blanchard J, Burns JM, Tevar AD, Edwards MJ, Lentsch AB (2012) Interleukin-37 reduces liver inflammatory injury via effects on hepatocytes and non-parenchymal cells. J Gastroenterol Hepatol 27(10):1609\u20131616. doi: 10.1111\/j.1440-1746.2012.07187.x","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"4258_CR10","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.cyto.2014.06.011","volume":"69","author":"FJ Patel","year":"2014","unstructured":"Patel FJ, Volkmann DT, Taylor GW, Hansson MA, Anderson JF, Zhou Y, Scoazec LM, Hartford CV, Hainz DL (2014) IL-37 reduces inflammatory response after cerebral ischemia and reperfusion injury through down-regulation of pro-inflammatory cytokines. Cytokine 69(2):234\u2013239. doi: 10.1016\/j.cyto.2014.06.011","journal-title":"Cytokine"},{"issue":"2","key":"4258_CR11","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/ki.2014.295","volume":"87","author":"Y Yang","year":"2015","unstructured":"Yang Y, Zhang ZX, Lian D, Haig A, Bhattacharjee RN, Jevnikar AM (2015) IL-37 inhibits IL-18-induced tubular epithelial cell expression of pro-inflammatory cytokines and renal ischemia-reperfusion injury. Kidney Int 87(2):396\u2013408. doi: 10.1038\/ki.2014.295","journal-title":"Kidney Int"},{"key":"4258_CR12","doi-asserted-by":"publisher","first-page":"4711","DOI":"10.1038\/ncomms5711","volume":"5","author":"DB Ballak","year":"2014","unstructured":"Ballak DB, van Diepen JA, Moschen AR, Jansen HJ, Hijmans A, Groenhof GJ, Leenders F, Bufler P, Boekschoten MV, Muller M, Kersten S, Li S, Kim S, Eini H, Lewis EC, Joosten LA, Tilg H, Netea MG, Tack CJ, Dinarello CA, Stienstra R (2014) IL-37 protects against obesity-induced inflammation and insulin resistance. Nat Commun 5:4711. doi: 10.1038\/ncomms5711","journal-title":"Nat Commun"},{"issue":"4","key":"4258_CR13","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.4049\/jimmunol.1300047","volume":"192","author":"X Teng","year":"2014","unstructured":"Teng X, Hu Z, Wei X, Wang Z, Guan T, Liu N, Liu X, Ye N, Deng G, Luo C, Huang N, Sun C, Xu M, Zhou X, Deng H, Edwards CK 3rd, Chen X, Wang X, Cui K, Wei Y, Li J (2014) IL-37 ameliorates the inflammatory process in psoriasis by suppressing proinflammatory cytokine production. J Immunol 192(4):1815\u20131823. doi: 10.4049\/jimmunol.1300047","journal-title":"J Immunol"},{"issue":"5","key":"4258_CR14","doi-asserted-by":"publisher","first-page":"e95346","DOI":"10.1371\/journal.pone.0095346","volume":"9","author":"PW Zhao","year":"2014","unstructured":"Zhao PW, Jiang WG, Wang L, Jiang ZY, Shan YX, Jiang YF (2014) Plasma levels of IL-37 and correlation with TNF-alpha, IL-17A, and disease activity during DMARD treatment of rheumatoid arthritis. PLoS One 9(5):e95346. doi: 10.1371\/journal.pone.0095346","journal-title":"PLoS One"},{"issue":"2","key":"4258_CR15","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1097\/MPG.0000000000000387","volume":"59","author":"S Weidlich","year":"2014","unstructured":"Weidlich S, Bulau AM, Schwerd T, Althans J, Kappler R, Koletzko S, Mayr D, Bufler P (2014) Intestinal expression of the anti-inflammatory interleukin-1 homologue IL-37 in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 59(2):e18\u201326. doi: 10.1097\/MPG.0000000000000387","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"4258_CR16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1479-5876-12-69","volume":"12","author":"L Ye","year":"2014","unstructured":"Ye L, Ji L, Wen Z, Zhou Y, Hu D, Li Y, Yu T, Chen B, Zhang J, Ding L, Du J, Huang Z (2014) IL-37 inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells of patients with systemic lupus erythematosus: its correlation with disease activity. J Transl Med 12:69. doi: 10.1186\/1479-5876-12-69","journal-title":"J Transl Med"},{"issue":"9","key":"4258_CR17","doi-asserted-by":"publisher","first-page":"e107183","DOI":"10.1371\/journal.pone.0107183","volume":"9","author":"Y Li","year":"2014","unstructured":"Li Y, Wang Z, Yu T, Chen B, Zhang J, Huang K, Huang Z (2014) Increased expression of IL-37 in patients with Graves\u2019 disease and its contribution to suppression of proinflammatory cytokines production in peripheral blood mononuclear cells. PLoS One 9(9):e107183. doi: 10.1371\/journal.pone.0107183","journal-title":"PLoS One"},{"key":"4258_CR18","doi-asserted-by":"publisher","first-page":"639712","DOI":"10.1155\/2013\/639712","volume":"2013","author":"C Li","year":"2013","unstructured":"Li C, Zhao P, Sun X, Che Y, Jiang Y (2013) Elevated levels of cerebrospinal fluid and plasma interleukin-37 in patients with Guillain\u2013Barre syndrome. Mediators Inflamm 2013:639712. doi: 10.1155\/2013\/639712","journal-title":"Mediators Inflamm"},{"issue":"1","key":"4258_CR19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4049\/jimmunol.170.1.107","volume":"170","author":"W Gao","year":"2003","unstructured":"Gao W, Kumar S, Lotze MT, Hanning C, Robbins PD, Gambotto A (2003) Innate immunity mediated by the cytokine IL-1 homologue 4 (IL-1H4\/IL-1F7) induces IL-12-dependent adaptive and profound antitumor immunity. J Immunol 170(1):107\u2013113","journal-title":"J Immunol"},{"key":"4258_CR20","doi-asserted-by":"publisher","first-page":"5177","DOI":"10.1038\/srep05177","volume":"4","author":"JJ Zhao","year":"2014","unstructured":"Zhao JJ, Pan QZ, Pan K, Weng DS, Wang QJ, Li JJ, Lv L, Wang DD, Zheng HX, Jiang SS, Zhang XF, Xia JC (2014) Interleukin-37 mediates the antitumor activity in hepatocellular carcinoma: role for CD57\u00a0+\u00a0NK cells. Sci Reps 4:5177. doi: 10.1038\/srep05177","journal-title":"Sci Reps"},{"issue":"1","key":"4258_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13046-016-0293-3","volume":"35","author":"G Ge","year":"2016","unstructured":"Ge G, Wang A, Yang J, Chen Y, Yang J, Li Y, Xue Y (2016) Interleukin-37 suppresses tumor growth through inhibition of angiogenesis in non-small cell lung cancer. J Exp Clin Cancer Res 35(1):13. doi: 10.1186\/s13046-016-0293-3","journal-title":"J Exp Clin Cancer Res"},{"key":"4258_CR22","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12967-015-0394-3","volume":"13","author":"B Chen","year":"2015","unstructured":"Chen B, Huang K, Ye L, Li Y, Zhang J, Zhang J, Fan X, Liu X, Li L, Sun J, Du J, Huang Z (2015) Interleukin-37 is increased in ankylosing spondylitis patients and associated with disease activity. J Transl Med 13:36. doi: 10.1186\/s12967-015-0394-3","journal-title":"J Transl Med"},{"issue":"4","key":"4258_CR23","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1159\/000349892","volume":"75","author":"JH No","year":"2013","unstructured":"No JH, Moon JM, Kim K, Kim YB (2013) Prognostic significance of serum soluble CD163 level in patients with epithelial ovarian cancer. Gynecol Obstet Invest 75(4):263\u2013267. doi: 10.1159\/000349892","journal-title":"Gynecol Obstet Invest"},{"issue":"4","key":"4258_CR24","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s00404-015-3704-3","volume":"292","author":"LY Zhang","year":"2015","unstructured":"Zhang LY, Li PL, Wang TZ, Zhang XC (2015) Prognostic values of 5-hmC, 5-mC and TET2 in epithelial ovarian cancer. Arch Gynecol Obstet 292(4):891\u2013897. doi: 10.1007\/s00404-015-3704-3","journal-title":"Arch Gynecol Obstet"},{"issue":"9","key":"4258_CR25","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.7314\/APJCP.2015.16.9.3635","volume":"16","author":"ML Gasparri","year":"2015","unstructured":"Gasparri ML, Attar R, Palaia I, Perniola G, Marchetti C, Di Donato V, Farooqi AA, Papadia A, Panici PB (2015) Tumor infiltrating lymphocytes in ovarian cancer. Asian Pac J Cancer Prev 16(9):3635\u20133638","journal-title":"Asian Pac J Cancer Prev"},{"issue":"6","key":"4258_CR26","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1080\/15384047.2015.1040960","volume":"16","author":"PP Santoiemma","year":"2015","unstructured":"Santoiemma PP, Powell DJ Jr (2015) Tumor infiltrating lymphocytes in ovarian cancer. Cancer Biol Ther 16(6):807\u2013820. doi: 10.1080\/15384047.2015.1040960","journal-title":"Cancer Biol Ther"},{"key":"4258_CR27","doi-asserted-by":"publisher","first-page":"14478","DOI":"10.1038\/srep14478","volume":"5","author":"X Shuai","year":"2015","unstructured":"Shuai X, Wei-min L, Tong YL, Dong N, Sheng ZY, Yao YM (2015) Expression of IL-37 contributes to the immunosuppressive property of human CD4+ CD25+ regulatory T cells. Sci Rep 5:14478. doi: 10.1038\/srep14478","journal-title":"Sci Rep"},{"issue":"8","key":"4258_CR28","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1093\/abbs\/gmv058","volume":"47","author":"W Wu","year":"2015","unstructured":"Wu W, Wang W, Wang Y, Li W, Yu G, Li Z, Fang C, Shen Y, Sun Z, Han L, Yu J, Fang L, Chen S, Dong K, Han Z, Liu H, Luo Y, Feng X (2015) IL-37b suppresses T cell priming by modulating dendritic cell maturation and cytokine production via dampening ERK\/NF-kappaB\/S6\u00a0K signalings. Acta Biochim Biophys Sin 47(8):597\u2013603. doi: 10.1093\/abbs\/gmv058","journal-title":"Acta Biochim Biophys Sin"},{"issue":"1","key":"4258_CR29","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nrd3683","volume":"12","author":"H Boehmer von","year":"2013","unstructured":"von Boehmer H, Daniel C (2013) Therapeutic opportunities for manipulating T(Reg) cells in autoimmunity and cancer. Nat Rev Drug Discov 12(1):51\u201363. doi: 10.1038\/nrd3683","journal-title":"Nat Rev Drug Discov"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-016-4258-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-016-4258-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-016-4258-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T01:52:34Z","timestamp":1498355554000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-016-4258-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,14]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["4258"],"URL":"https:\/\/doi.org\/10.1007\/s00404-016-4258-8","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,14]]}}}